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Abstract The complement (C) plays an important role in many
acute inflammatory processes. C3a is an inflammatory polypep-
tide named anaphylatoxin, generated during C activation and
which acts through a specific receptor C3aR. In this study, we
demonstrated that the epithelial cell line ECV 304 constitutively
expressed C3aR (by flow cytometry and immunofluorescence)
and that binding of purified C3a to epithelial cells resulted in a
time- and dose-dependent upregulation of interleukin-8 (IL-8).
Pre-treatment of ECV 304 with pertussis toxin inhibited IL-8
response induced by C3a, indicating that the action of C3a was
mediated by a G protein coupled pathway. ß 2001 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
The immune system is essential for protection of the host
organism and the complement (C) system is an important
component of this immune system.
The early stage of in£ammatory process leads to the acti-
vation of the C system. One of the biological consequences of
this activation is the release of potent proin£ammatory mol-
ecules, the C3a and C5a anaphylatoxins, which are powerful
chemoattractants and which recruit neutrophils, macrophages
and mast cells at the in£ammatory site. Activation of the
immunocompetent cells leads to the phagocytose of invading
pathogens [1].
C3a and C5a anaphylatoxins are generated by proteolytic
cleavage from C3 and C5 components, respectively. C5a, the
best characterised anaphylatoxin is a potent proin£ammatory
mediator that induces contraction of smooth muscles, enhan-
ces the vascular permeability and promotes leukocyte func-
tions such as directed chemotaxis, degranulation, mediator
release (including histamine, interleukin-1 (IL-1), IL-6, IL-8
and tumour necrosis factor (TNF) K), increased expression
of adhesion molecules and production of superoxide anions
[2^5]. C3a can also drive its own proin£ammatory activities
such as degranulation and chemotaxis of eosinophils and hu-
man mast cells and induces platelet aggregation [6^8]. Cells
respond to anaphylatoxins via interaction with speci¢c recep-
tors, which belong to the seven transmembrane receptor
superfamily and that are functionally coupled to G proteins
[9,10].
The receptor for C5a (C5aR) was cloned in 1990 [11]. The
expression of this receptor was traditionally thought to be
restricted to granulocytes, monocytes and macrophages and
cell lines of myeloid origin [12,13]. However, recent reports
indicate that a variety of non-myeloid cells (including human
hepatocytes, epithelial cells, endothelial cells, vascular smooth
muscle and glial cells) also express C5aR [14^20]. The broad
distribution of C5aR suggests it plays an important role in
modulating in£ammatory and immune responses.
The cloning of C3a receptor (C3aR) has recently been re-
ported but little is known about the cellular and tissue distri-
bution of the C3aR [21^23]. Binding and functional experi-
ments have indicated that C3aR was present on monocyte/
macrophage cells, platelets, polymorphonuclear leukocytes,
rat mast cells and basophils [13,24^28]. Furthermore, the mye-
lomonocyte U937 and myeloblastic HL60 cell line express a
C3aR when di¡erentiated to a more mature phenotype by
treatment with dibutyryl cyclic adenosine monophosphate
[29].
However, little is known about the expression of C3aR at
the protein level and on non-myeloid cells. If C5aR was de-
scribed on epithelial cells, nothing is known about it’s expres-
sion and role.
The immune system is essential to eliminate a large variety
of pathogens and for the protection of the host organism.
This task requires concerted actions of cellular responses
that are regulated by a network of cytokines. The e¡ects of
C5a on cytokine production are well characterised. C5a is a
potent inducer of gene expression and protein synthesis for
TNF K, IL-1, IL-6 and IL-8 [30^33].
On the contrary the e¡ects of C3a as an inducer of cytokine
production remain ill characterised and nothing is known
about the e¡ects of C3a on epithelial cells.
Thus, the purpose of the present study was to identify the
expression of the C3aR on epithelial cells and to explore the
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mechanism by which C3a drives in£ammatory epithelial cell
responses. C3a was assessed for it’s ability to modulate IL-8
production on epithelial cells.
Here we described for the ¢rst time the expression of C3aR
on epithelial cell line ECV 304. C3aR expression was demon-
strated at the protein and mRNA levels. C3a in addition to
being direct mediator of in£ammation can induce an increased
level of IL-8 from epithelial cells. These results suggest that
anaphylatoxin contributes to both in£ammation and regula-
tion of the immune function by modulating IL-8.
2. Materials and methods
2.1. Chemicals, cytokines and antibodies
The following materials were purchased from Sigma, St. Quentin
Fallavier, France: pertussis toxin (PTX), zymosan A, phorbol myris-
tate acetate (PMA) and S100.
Monoclonal anti-C3aR: clone BIIG1 IgG2a was from Dr. Philippe
Gasque, Cardi¡, UK.
Rabbit anti-human C3aR: peptide cut was from Dr. Philippe Gas-
que, Cardi¡, UK and was characterised as described [24].
Antibodies against human CD59 (clone BRIC 229) were from Paul
Morgan, Cardi¡, UK.
2.2. Peptides
Multiple-assay-peptide (MAP) C3a peptides were synthesised by
solid phase synthesis (Applied Biosystem). Peptides were puri¢ed by
reverse phase high performance liquid chromatography (HPLC) and
sequences were ascertained by amino-acid sequence. MAP C3a pep-
tides correspond to the C-terminal of the anaphylatoxins (amino acids
64^77 for the C3a) attached to a poly-lysine core (eight peptidic
monomers).
Human C3a was generated by activation of C using zymosan A
(Sigma). 1 l of fresh human serum from healthy volunteers (CRTS,
Bois guillaume, France) was supplemented with EGTA (10 mM),
MgCl2 (10 mM), O-aminocaproic acid (50 mM) and DL-2 (mercap-
toethyl) guanidinopentanoic acid (1.5 mM). C was activated by 20 g
of washed zymosan A during 1 h at 37‡C with gentle stirring. At the
end of incubation, the pH was lowered to 5.2 by addition of HCl. The
mixture was diluted with an equal volume of cold distilled water and
centrifuged at 4‡C, 1 h, 18 000Ug. The supernatant was adjusted to
1 M NaCl and subjected to immunoa⁄nity chromatography on a
150 ml Sepharose anti-C3a column.
After intensive washing of the column with 1 M NaCl, phosphate-
bu¡ered saline (PBS) bu¡er, C3a was eluted with 0.1 M glycine^HCl,
1 M NaCl bu¡er pH 2.2. Solid urea was added to C3a containing
fractions (8 M ¢nal concentration) which were concentrated by ultra-
¢ltration on YM-5 membrane (Amicon, Paris, France). Puri¢cation
was achieved by gel ¢ltration on a TSK G2000 SW HPLC column
(Beckman, Gagny, France) equilibrated in 20 mM sodium phosphate,
0.2 M NaCl pH 7.4.
The purity of C3a after gel ¢ltration was assessed by sodium do-
decyl sulphate (SDS)^polyacrylamide gel electrophoresis and Coomas-
sie blue staining. The immunoreactivity was checked by Western blot-
ting using monoclonal anti-C3a antibody (Ab) and rabbit anti-C3a.
2.3. Cell culture
ECV 304 epithelial cell line as well as K562, U937, HL60, Jurkat
cell lines was obtained from American type culture collection (Rock-
ville, MD, USA) and cultured at 37‡C in RPMI 1640 supplemented
with 2 mM L-glutamine, 50 Wg/ml penicillin, 50 Wg/ml streptomycin
and 10% heat-inactivated foetal calf serum (Bioproducts, Gagny,
France). Cell culture reagents were from Biowhittaker unless other-
wise stated.
For some experiments, cells were stimulated with PMA (10 ng/ml)
for 48 h.
All cell lines were tested for mycoplasma according to the manu-
facturer’s instructions (Boehringer Mannheim, Germany).
2.4. Flow cytometry
Adherent epithelial cells were harvested by incubation in £uores-
cence analysis cell sorter (FACS) bu¡er (saline bu¡er containing 2%
bovine serum albumin (BSA) supplemented with 10 mM EDTA), and
resuspended at 106 cells/ml, washed twice and incubated with the
appropriate primary Ab (10 Wg/ml) for 30 min on ice, washed twice
in ice cold FACS bu¡er, incubated with the appropriate phycoery-
thrine (PE)-labelled secondary Ab (goat anti-rabbit Ig diluted 1/200,
Dako) for 30 min on ice and washed two additional times before
analysis on a £ow cytometer FASCscalibur (Becton Dickinson, Pont
de Claix, France). The negative control consisted of cells incubated
with non-immune rabbit IgG only. Data from several experiments
were normalised to the staining with non-speci¢c mouse IgG as a
negative control and are expressed as arbitrary £uorescence units.
2.5. RNA preparation
Total RNAs were isolated from cultured cells using isothiocyanate
guanidium and an ultracentrifugation on a cesium chloride cushion
followed by phenol/chloroform extraction described previously by
Shambrook et al. [34]. The quality of RNAs was controlled by elec-
trophoresis on a 1% agarose gel and concentration was determined by
absorbance at 260 nm.
50 Wg of the total RNAs were treated for 20 min at 37‡C with 90 U
of RQ-1 RNAse-free DNAse (Promega, Charbonnie'res, France) in
100 Wl of bu¡er (40 mM Tris^HCl pH 8, 10 mM NaCl, 6 mM MgCl2
and 10 mM CaCl2) and 200 U of RNAsin ribonuclease inhibitor
(Promega) to remove all traces of contaminating genomic DNA.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
The RT reaction was carried out with 2 Wg of total RNA (DNAse
treated) for 1 h at 37‡C in a ¢nal volume of 30 Wl with 250 pmol
random hexamer primer Pd(N)6 (Pharmacia, Orsay, France), 200 U
Moloney murine leukaemia virus (MMLV) reverse transcriptase
(Promega) and 40 U RNAse inhibitor (Promega). The absence of
contaminants was routinely checked on negative control samples in
which either the RNA template was replaced with diethyl pyrocar-
bonate water or the MMLV reverse transcriptase was omitted.
PCR was performed in a Hybaid Omnigene thermocycler (Schleich-
er and Schuell, Ce¤ra labo, France) with 5 Wl of cDNA in a 50 Wl ¢nal
volume with 2.5 mM MgCl2 (Promega), 200 WM deoxynucleotide
triphosphates (Pharmacia), 100 pmol of each C3aR primer (Eurogen-
tec, Belgium) and 2.5 U of Taq polymerase (Promega) in the PCR
bu¡er. The di¡erent PCR steps were: denaturation for 3 min at 94‡C;
¢ve cycles (394‡C 40 s, annealing at 56‡C for 50 s and elongation at
72‡C for 90 s, ramping 6 s/‡C up from 56 to 72‡C); 25 cycles under
the same conditions as above but without ramping; end of elongation
at 72‡C for 10 min, and 5 min to return to room temperature.
RT-PCR products were loaded onto 1% agarose gel and separated
by electrophoresis.
Di¡erent controls were performed (no RT or Southern blot) to
ensure the validity of the RT-PCR. All products were also sequenced.
The sequences and the position of the primers used in this study are
given as follows: C3aR sense-1: GGG TGG TGG CTT TTG TGA
TG (521); C3aR sense-2: GTC CCC ACT GTC TTC CAA CC (754);
C3aR antisense-1P : CAG CAG GAA ACC CAC CAC TA (1122);
C3aR antisense-2P : AGG GCA TAA AGG AAG GGA TT (1391);
IL-8 sense: TCT TGG CAG CCT TCC TGA TT; IL-8 antisense:
AAC TTC TCC ACA ACC CTC TG; glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) sense: TGC CAT CAA CGA CCC CTT
CA; GAPDH antisense: TGA CCT TGC CCA CAG CCT TG.
For semi-quantitative RT-PCR, PCR was carried out with 25 pmol
of each primer, 1.25 pmol of each GAPDH primer and 1 WCi
[33P]dATP (Redivue, Amersham, les Ulis, France). Primers were
used with a GAPDH:cytokine molar ratio of 1:10. The number of
cycles was chosen in order not to reach the plateau (25 cycles). PCR
products were loaded onto a 6% acrylamide gel and separated by
electrophoresis migration. Gels were dried and exposed onto Biomax
Films (Kodak Films, Sigma, St. Louis, MO, USA). Autoradiograms
were analysed by densitometry using Lecphor imaging system soft-
ware (Biocom, Les Ulis, France).
The relative amount of each cytokine mRNA was estimated by
dividing the peak densitometry area of the cytokine amplicon by
this of the GAPDH amplicon.
The level of cytokine mRNA expression from unstimulated cells
was set to one arbitrary unit and values for the stimulation time
were calculated accordingly.
2.7. Southern blot
The human C3aR DNA was constructed by RT-PCR of PMA
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stimulated U937 RNA using C3aR sense 1 and C3aR antisense 1
primers.
Agarose gel electrophoresis was performed with 10 Wl of RT-PCR
products.
The gel was treated for 10 min in 0.15 N HCl and neutralised for
30 min in 0.4 N NaOH. Southern blotting was performed by capillary
transfer during 16 h in 0.4 N NaOH on nylon plus membranes (Amer-
sham, France).
The blot was neutralised for 10 min in saline^sodium phosphate^
EDTA bu¡er (SSPE) 2U. The human C3aR probe was labelled by
random priming with [K-32P]dCTP (Redivue, Amersham, Les Ulis,
France) using the kit Rediprime II (Amersham). The membrane was
prehybridised at 42‡C for 4 h in a hybridisation solution (50% form-
amide, SSPE 5U, SDS 0.1%, Denhardt solution 5U, dextran sulphate
5% and 100 Wg/ml herring sperm DNA).
Hybridisation was performed at 42‡C overnight in the hybridisation
solution as above supplemented with the labelled probe.
The membrane was washed twice at room temperature in SSPE
2U/SDS 0.1%, 1 h in SSPE 2U/SDS 0.1% at 65‡C and 1 h at 65‡C
in SSPE 1U/SDS 0.1% and exposed 20 min at room temperature onto
Kodak Films (Sigma).
2.8. Immunocytochemistry
Epithelial cells were cultured on sterile glass coverslips for 4 days.
After washing with PBS, the cells were ¢xed with 1% formaldehyde
(Sigma) for 30 min and then cells were washed intensively with 0.2 M
glycine/PBS. Abs were used at an optimal dilution of 1 Wg/ml in PBS/
BSA 1% and incubated at 37‡C for 30 min. After washing, coverslips
were incubated for 30 min at 37‡C with anti-mouse IgG (FabP)2 £uo-
rescein isothiocyanate (FITC) conjugate or goat anti-rabbit-FITC
conjugate (1/200) (Harlan seralab, Crowley Down, UK). After wash-
ing, coverslips were mounted in citi£uor (Citi£uor, London, UK) and
sealed. Fluorescence was imaged by confocal laser scanning micros-
copy on a Leica TCS microscope.
2.9. IL-8 enzyme-linked immunosorbent assay (ELISA)
96-well plates (Costar, Corning, NY, USA) were incubated with
monoclonal anti-human IL-8 Ab (T9g10, 1 Wg/ml) in 0.05 M borate
bu¡er, pH 8 and subsequently blocked with PBS containing 1% BSA.
After washing, appropriate dilutions of samples were added, incu-
bated for 1 h at room temperature, washed and then incubated with
a monoclonal biotinylated anti-human IL-8 (diluted 1:2000) for 1 h at
room temperature. After washing, the wells were incubated with
streptavidin-peroxidase (Sigma, 1/3000). The substrate of the peroxi-
Fig. 1. a: Expression of C3aR mRNA by epithelial cell line ECV 304 and control cell line THP1 and U937: RT-PCR analysis. The expression
of C3aR was assessed by RT-PCR using four di¡erent combinations of C3aR primers. L represents the size marker (100 bp ladder, Promega).
Lane 1 represents a negative control in which the RT reaction product was omitted. Lane 2, epithelial cell line ECV 304. Lane 3, 48 h phorbol
ester (PMA) treated U937. Lane 4, THP1. b: RT-PCR analysis to test C3aR expression followed by Southern blotting using a speci¢c human
C3aR cDNA probe. Lane 1, U937/PMA. Lane 2, THP1/PMA. Lane 3, ECV 304. Lane 4, ECV 304 without MMLV without treatment.
Table 1
Immunodetection of C3aR on epithelial cells by FACS analysis
Mean of £uorescence (FL2-H channel) (PE staining)
rabbit anti-C3aR
peptide cut
rabbit anti-C3aR
peptide cut biotinylated
BIIG1 Bric 229
THP1 (n = 10) 28.13 þ 9.75 96.05 þ 36.53 118.05 þ 38.73 1.11 þ 1.02
Jurkat (n = 6) 1.47 þ 1.02 1.70 þ 1.18 2.83 þ 0.57 ND
ECV 304 (n = 7) 40.82 þ 17.34 91.82 þ 61.80 222.36 þ 165.30 1697.57 þ 711.82
C3aR-transfected K562 (n = 4) 1098 þ 21 1673.50 þ 28.50 1810 þ 41.30 ND
Vector only K562 (n = 3) 2.99 þ 0.21 4.80 þ 0.07 6.20 þ 0.3 ND
All the results are represented as the mean þ S.E.M.
Cells were harvested from culture by incubation in FACS bu¡er supplemented with 10 mM EDTA. Cells were washed and resuspended at 106
cells/ml and incubated with the appropriate Ab: rabbit IgG or rabbit anti-human C3aR peptide cut, rabbit anti-human C3aR peptide cut bio-
tinylated, monoclonal anti-human C3aR (BIIG1) or monoclonal anti-CD59 (clone BRIC229); ND: not determined.
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dase used was the O-phenylenediamine and the cytokine concentra-
tion was calculated relatively to IL-8 standards.
ECV 304 was stimulated with/without anaphylatoxin, supernatants
were harvested and stored at 380‡C and cells were counted in a
Mallasez cell. The levels of IL-8 released into the culture supernatants
were measured and expressed as pg/ml of IL-8 per 105 cells.
3. Results
3.1. Human epithelial cell line (ECV 304) constitutively
expresses a C3aR mRNA
C3aR mRNA expression by ECV 304 epithelial cell line was
analysed using RT-PCR analysis (Fig. 1a).
Four oligonucleotide combinations (oligo 1/1P, 1/2P, 2/2P
and 2/1P) were tested for RT-PCR analysis. After 30 cycles
the predicted amplicon sizes of 601, 870, 368 and 637 bp were
detected from the epithelial cell line ECV 304 (lane 2) and the
PMA di¡erentiated U937 (lane 3) and THP1 (lane 4) cell
lines.
All RNA samples were pre-treated with DNAse to elimi-
nate contamination with genomic DNA and this was con-
¢rmed by the absence of a PCR fragment when RT product
was omitted (lane 1).
The identity of the di¡erent PCR products from ECV 304
was con¢rmed by Southern blot analysis using a speci¢c
C3aR cDNA probe cloned from U937 (Fig. 1b). U397 (lane
1) and THP1 (lane 2) stimulated with PMA were used as
positive control. The absence of contamination with genomic
DNA was con¢rmed by the absence of a PCR fragment when
RT product was omitted (lane 4)
Furthermore, all PCR products from ECV 304 were se-
quenced and were identical with the published sequence
(data not shown).
3.2. Human epithelial cell (ECV 304) constitutively expresses
membrane C3aR at the cell membrane (Table 1)
Two di¡erent Abs against the extracellular loop of the
Fig. 2. Immunolocalisation of C3aR on ECV 304 endothelial cell line by indirect IF and analysis by confocal laser microscopy. Cells were incu-
bated with either (b) rabbit anti-C3aR (1/200) followed by an FITC-conjugated goat anti-rabbit Ig Ab or with (d) monoclonal anti-C3aR
BIIG1 (1/500) followed by an FITC-conjugated rabbit anti-mouse IgG Ab. Cells were also incubated with (f) BRIC 229 (mouse anti-human
CD59) and (g) S100 as positive control. Extended focus views demonstrated that £uorescence was localised on the membrane. The nucleus of
the cells was visualised by DAPI staining (1/2000) (c and h). C3aR staining was patchy and localised in restricted areas of the membrane. Con-
trols consisted of cells incubated with the second Ab alone, which means goat anti-mouse IgG^FITC conjugate (a) or goat anti-rabbit^FITC
conjugate (d).
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C3aR were used for FACS analysis to detect the expression of
human C3aR on epithelial cell line ECV 304. ECV 304 ex-
hibited a mean of £uorescence of 222.36 þ 165.30 when la-
belled with the monoclonal Ab BIIG1. The same experiment
was carried out with the polyclonal Ab biotinylated or not.
ECV 304 exhibited a mean of £uorescence of 91.8 þ 61.8.
The speci¢city of these Abs was con¢rmed by staining of
THP1, U937 and K562 cells, an erythroleukaemia cell line,
transfected with vector Pef bos containing C3aR cDNA. Neg-
ative controls consisted of mocked cells (vector only K562).
K562 transfected with Pef bos express a mean of £uorescence
of 1810 þ 41.30 with the monoclonal Ab BIIG1 and a mean of
£uorescence of 1673.50 þ 28.50 with the polyclonal Ab. The
negative control K562 containing the vector only showed a
weak mean of £uorescence (6.20 þ 0.30) with the monoclonal
Ab BIIG1 as well as with the polyclonal Ab (4.8 þ 0.07).
A staining was also performed against CD59 antigen to
check the quality of the cells.
Indirect immuno£uorescence (IF; Fig. 2) con¢rmed that
C3aR was expressed abundantly on the membrane of ECV
304 epithelial cell line.
The IF staining of epithelial cell line ECV 304 was shown
with BIIG1 (the monoclonal Ab directed against the extracel-
lular loop) (Fig. 2e) and con¢rmed by using the polyclonal
Ab. Cells were strongly stained for C3aR with polyclonal Ab
(Fig. 2b). Positive controls were used as staining for CD59
(Fig. 2f) and S100 protein (Fig. 2g). The distribution of C3aR
over the epithelial cell was not homogeneous but localised in
discrete patches on the cell body (Fig. 2b,e). C3aR was not
observed in the nucleus or the cytoplasm. No staining was
observed when the anti-C3aR was replaced with the second
Ab alone, either goat anti-mouse IgG^FITC conjugate (Fig.
2a) or goat anti-rabbit^FITC conjugate (Fig. 2d). The nucleus
of the cell was visualised by 4P,6-diamidino-2-phenylindole
(DAPI) staining (Fig. 2c,h).
IL-8 is a central cytokine, which plays a central role in the
in£ammatory process by recruiting in£ammatory cells. We
decided to study the expression of this cytokine by stimulating
epithelial cells with a range of concentration of anaphylatox-
ins and during di¡erent times. Epithelial cells at around 80%
con£uent were incubated with di¡erent concentrations of ana-
phylatoxin C3a and then the RNAs were extracted and RT-
PCR was performed.
3.3. Stimulation of epithelial cell line with 1039 M MAP C3a
and 1038 M C3a increases IL-8 mRNA
The IL-8 mRNA level was increased at 1 h of poststimula-
tion with C3a and MAP C3a (Fig. 3). The IL-8 mRNA level
was markedly increased by 2.5-fold for MAP C3a and 2.7-fold
for C3a after 1 h of stimulation. The level of IL-8 was in-
creased 2.4-fold for MAP C3a and 2.5-fold for C3a and re-
mained high at 3 h. The level of IL-8 mRNA remained at a
higher level than that of non-stimulated cells even at 6 and 9 h
of stimulation for MAP C3a and C3a.
3.4. Anaphylatoxin-induced IL-8 mRNA response was
dose-dependent
Epithelial cell line ECV 304 was stimulated by a range of
concentration of MAP peptides and anaphylatoxins from
1037 to 10311 M.
Total RNAs were extracted at 1 h of stimulation for C3a,
which corresponded to the peak of IL-8 response for MAP
C3a and C3a. The optimal response corresponded with 1039
M of stimulation for MAP C3a and 1038 M for C3a (data not
shown). These results are in good agreement with previous
responses that show a stronger agonist e¡ect of MAP C3a
over C3a [35,36].
3.5. C3a-mediated increases in IL-8 production in ECV 304
are PTX sensitive (Fig. 4)
C3a is known to bind to a receptor that is functionally
coupled to a G protein [9,10]. In addition, cloning of human
C3aR con¢rmed that it possesses the structure of a G protein
coupled receptor. Therefore, we wondered if the observed ef-
fects of C3a on the IL-8 level were subject to inhibition by
Fig. 3. Semi-quantitative RT-PCR analysis of IL-8 mRNA expres-
sion following stimulation of ECV 304 cells with MAP C3a (1039
M) or C3a (1038 M). RNAs were extracted at 1, 3, 6 and 9 h of
stimulation and analysed by semi-quantitative RT-PCR using
GAPDH as internal standard. Results are represented as histograms
and expressed as relative fold increase over control (NS: non-stimu-
lated cells). All results are represented as mean þ S.D.
Fig. 4. In£uence of PTX on the IL-8 mRNA production by epitheli-
al cells following stimulation with C3a and MAP C3a. ECV 304
were incubated during 4 h with PTX (500 ng/ml) and then stimu-
lated with 1038 M C3a, or with 1039 M of MAP C3a during 1 h.
Epithelial cells were also incubated with PTX alone. Total RNAs
were extracted and RT-PCR was performed. Control consists of
non-stimulated cells (NS). All results are represented as the
mean þ S.D. (n = 4).
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PTX. The pre-treatment of cells with PTX is known to inter-
fere with signals mediated through Gi-protein as demon-
strated in neutrophils [9]. Cells were preincubated with PTX
4 h prior to stimulation and then stimulated for 1 h with C3a.
To con¢rm that PTX had no e¡ect on cells, epithelial cells
were incubated with PTX alone. The level of IL-8 mRNA
after incubation with PTX alone is comparable with this of
non-stimulated cells. Controls of the blocking e¡ect of PTX
consisted of cells stimulated with peptides alone (during 1 h
for MAP C3a and C3a). Pre-treatment of ECV 304 with PTX
reduced the IL-8 mRNA level. In the same way, pre-treatment
of ECV 304 with PTX prior to stimulation with puri¢ed C3a
blocked the IL-8 mRNA response.
3.6. Epithelial cell line ECV 304 stimulated by anaphylatoxins
induce a IL-8 protein production
To determine the e¡ect of C3a on the ability of epithelial
cells to produce IL-8, layers of quiescent epithelial cells were
incubated at 37‡C and for 72 h with di¡erent concentrations
of C3a (Fig. 5). The supernatants of ECV 304 cells stimulated
with anaphylatoxin were harvested after 72 h of stimulation
and the concentration of IL-8 in appropriate dilutions of
supernatants was assessed by speci¢c sensitive ELISA assay
(20 pg/ml). A basal level of IL-8 produced by epithelial cells
was detected (92 þ 18 pg/ml).
Furthermore, epithelial cells stimulated with increasing con-
centrations of C3a showed a dose-dependent production of
IL-8 (maximum 998 þ 42 pg/ml for C3a).
Based on these results, an optimal stimulation concentra-
tion of 1038 M for C3a (Fig. 6) was chosen.
We then investigated the kinetics of IL-8 production. Qui-
escent epithelial cells were stimulated with 1038 M of C3a for
di¡erent incubation times (from 6 to 72 h).
These kinetics revealed a time-dependent production of IL-
8 with a maximum production at 72 h for C3a (953 þ 49 pg/
ml). No signi¢cant variation of IL-8 was detected when epi-
thelial cells were cultured over 72 h.
Since C3a and C5a are known to interact via a speci¢c
receptor coupled to a G protein, we assessed the e¡ect of
PTX on epithelial cells preincubated with PTX 4 h prior to
the stimulation with anaphylatoxins C3a. Addition of PTX
prior to stimulation with C3a decreased the IL-8 production
to the level observed with non-stimulated cells. Preincubation
of epithelial cells with PTX alone did not a¡ect the IL-8
production (data not shown).
4. Discussion
C is an integral buttress of the in£ammatory reaction. Some
functions of C include opsonisation, clearance of circulating
immune complexes, lysis of nucleated and non-nucleated cells
and lysis of bacteria. In addition to these activities, the C
generated anaphylatoxins C3a and C5a [37]. The importance
of anaphylatoxins as major participants in in£ammatory pro-
cesses is suggested by elevated plasma levels of C3a and C5a
in local and systemic in£ammatory conditions and as much as
60 Wg/ml of C3a can be generated in activated human serum.
In the present study, we investigated the e¡ects of anaphy-
latoxins on epithelial cells. We were interested to assess
whether epithelial cells could express C3aR and to obtain
further insight on the potential roles of C3a on epithelial cells
in the general context of in£ammation. For that purpose, we
decided to examine the e¡ects of anaphylatoxin on K chemo-
kine IL-8 production by human epithelial cells. Indeed, IL-8 is
of importance because it is involved in the attraction of neu-
trophils to the site of in£ammation.
Until now, little work has been conducted on the e¡ect of
anaphylatoxins on epithelial cells.
Previous studies have demonstrated that C5aR is present on
bronchial and alveolar epithelial cells [14,38] but nothing is
known concerning C3aR.
First of all, the use of highly speci¢c Abs reactive with the
predictive large extracellular loop of the C3aR and molecular
Fig. 6. Time-dependent production of IL-8 by epithelial cells after
incubation with C3a (1038 M). Layers of quiescent epithelial cells
were incubated with 1038 M of C3a or with medium alone for dif-
ferent lengths of time. Using a speci¢c ELISA, the concentration of
IL-8 was measured in the supernatants. The results are represented
as the mean þ S.D. of three di¡erent experiments.
Fig. 5. Dose-dependent production of IL-8 by epithelial cells after
incubation with increasing concentrations of C3a. Con£uent layers
of epithelial cells were rendered quiescent by overnight incubation
with ultradoma medium and were then incubated for 72 h with me-
dium containing di¡erent concentrations of C3a (from 0.05U1038
M to 5.5U1038 M). The mean production þ S.D. is shown for ex-
periments performed in triplicate.
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probes allowed us to characterise expression of the C3aR
protein in an epithelial cell line. The FACS analysis has re-
vealed expression of C3aR by epithelial cells.
We then observed the distribution of C3aR on individual
cells ; this distribution was not homogeneous and C3aR was
present in dense patches on the membrane; the distribution
observed on epithelial cells was similar to that observed for
C5aR on astrocytes [15]. Other proteins stained using the
same protocol gave a homogeneous distribution pattern on
epithelial cells, eliminating the possibility that this patched
distribution of C3aR was an artefact. As this was suggested
before [24], the enrichment of C3aR at localised areas on the
membrane surface could enhance the ability of epithelial cells
to respond to the anaphylatoxins.
To better understand the involvement of C3a anaphylatoxin
in in£ammation in general, we investigated the e¡ects of C3a
on epithelial cells. We demonstrated that interaction of C3a
with epithelial cells enhanced the production of IL-8 in a
dose- and time-dependent manner.
Involvement of anaphylatoxins in the processes of in£am-
mation is well established [4,39].
Previous works have shown a role of C3a in the regulation
of cytokine synthesis [40]. In the same way, C5a has been
previously shown to induce the synthesis and secretion of a
number of proin£ammatory cytokines including IL-1 L and
IL-8 [30,31]. We found that C3a induced IL-8 mRNA and
that IL-8 is released from epithelial cells after 12 h of post-
stimulation by C3a and the peak of IL-8 mRNA is reached
between 1 and 3 h of poststimulation by C3a. MAP C3a, an
analogue of the C3a peptide, also increases IL-8 mRNA sug-
gesting that the observed e¡ects of C3a on IL-8 production
are speci¢c and not due to contaminants in the C3a prepara-
tion. In fact the study was ¢rst conducted with peptidic ana-
phylatoxin analogue MAP C3a that bears strong agonist
properties [33].
Anaphylatoxins induced an IL-8 mRNA increase in a dose-
dependent manner, with an optimal concentration of 1039 M
for MAP peptide and 1038 M for anaphylatoxin.
The di¡erence in reactivity between C3a and MAP peptide
analogue is due to the superagonist properties of this ana-
logue as demonstrated previously [35,36]. The concentration
range in which C3a is active is in good agreement with the
C3aR a⁄nity constant for C3a (Kd, 2^5 nM) A dose-depen-
dent curve with an optimal concentration for anaphylatoxin
of 1038 M has also been observed for chemotactic action on
monocytes [41]. The results observed with MAP C3a and C3a
were similar. The IL-8 mRNA increase observed with MAP
peptide was con¢rmed with puri¢ed C3a.
Recently, the C3aR cDNA was cloned [21^23] and the
C3aR was found to belong to the family of the seven trans-
membrane receptor. Moreover, several biological responses of
C3a can be blocked by PTX, suggesting that the C3aR acts as
a Gi coupled receptor.
In the present study, we showed that pre-treatment of epi-
thelial cells with PTX for 4 h blocked the C3a-mediated en-
hancement of IL-8 mRNA, indicating that this molecule acts
through a G protein coupled pathway, possibly involving the
C3aR. This could be con¢rmed later by using a blocking Ab.
IL-8 was also investigated at the protein level. Supernatants
were tested with a speci¢c ELISA assay and showed an up-
regulation of IL-8 following stimulation by C3a anaphylatox-
in. The upregulation of IL-8 released after stimulation with
anaphylatoxin was previously described with monocytes
[41,42].
IL-8 is an important cytokine, which is released during in-
£ammation. Attraction of in£ammatory cells is predominantly
mediated by IL-8, which belongs to the superfamily of chemo-
kines [43].
It is now well established that anaphylatoxin receptors are
present on non-myeloid cells [14^23]. Previously the presence
of C5aR on epithelial cells was thought to be particularly
relevant of the lung since C5a has been implicated as a medi-
ator of acute lung injury [38]. However, C5aR has recently
been demonstrated to be expressed in normal renal proximal
tubular but not in normal pulmonary or hepatic epithelial
cells [44] suggesting that C5aR may have other roles than a
modulatory role for C5a/C5aR in the airway in£ammatory
system. As it has been studied for C5aR, it is di⁄cult to
¢nd out a general function for C3aR on epithelial cells as it
depends on the origin of the epithelial cells. Indeed epithelial
cells are widely spread through the body and exhibited di¡er-
ent characteristics according to the origin. By in£uencing IL-8
production in epithelial cells, C3a and its receptor may con-
tribute to the regulation of both immune responses and in-
£ammation.
This idea has already been suggested by the fact that the
deletion of C5aR in mice has revealed that C5aR is important
in mice in the protection against infection by bacterium Pseu-
domonas aeruginosa [45]. The expression of C3aR on epithelial
cells in in£ammation conditions could be important in perpet-
uation of in£ammatory response.
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